BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wildgruber M, Stadlbauer T, Rasper M, Hapfelmeier A, Zelger O, Eckstein HH, Halle M, Rummeny EJ, Huber AM. Single-dose gadobutrol in comparison with single-dose gadobenate dimeglumine for magnetic resonance imaging of chronic myocardial infarction at 3 T. Invest Radiol 2014;49:728-34. [PMID: 24872002 DOI: 10.1097/RLI.0000000000000076] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Szűcs A, Kiss AR, Suhai FI, Tóth A, Gregor Z, Horváth M, Czimbalmos C, Csécs I, Dohy Z, Szabó LE, Merkely B, Vágó H. The effect of contrast agents on left ventricular parameters calculated by a threshold-based software module: does it truly matter? Int J Cardiovasc Imaging 2019;35:1683-9. [PMID: 31037474 DOI: 10.1007/s10554-019-01587-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
2 Kuetting DL, Dabir D, Homsi R, Sprinkart AM, Luetkens J, Schild HH, Thomas DK. The effects of extracellular contrast agent (Gadobutrol) on the precision and reproducibility of cardiovascular magnetic resonance feature tracking. J Cardiovasc Magn Reson 2016;18:30. [PMID: 27209219 DOI: 10.1186/s12968-016-0249-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
3 D'Angelo T, Grigoratos C, Mazziotti S, Bratis K, Pathan F, Blandino A, Elen E, Puntmann VO, Nagel E. High-throughput gadobutrol-enhanced CMR: a time and dose optimization study. J Cardiovasc Magn Reson. 2017;19:83. [PMID: 29110679 DOI: 10.1186/s12968-017-0400-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
4 Stillman AE, Oudkerk M, Bluemke DA, de Boer MJ, Bremerich J, Garcia EV, Gutberlet M, van der Harst P, Hundley WG, Jerosch-Herold M, Kuijpers D, Kwong RY, Nagel E, Lerakis S, Oshinski J, Paul JF, Slart RHJA, Thourani V, Vliegenthart R, Wintersperger BJ. Imaging the myocardial ischemic cascade. Int J Cardiovasc Imaging 2018;34:1249-63. [PMID: 29556943 DOI: 10.1007/s10554-018-1330-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
5 Francis R, Kellman P, Kotecha T, Baggiano A, Norrington K, Martinez-Naharro A, Nordin S, Knight DS, Rakhit RD, Lockie T, Hawkins PN, Moon JC, Hausenloy DJ, Xue H, Hansen MS, Fontana M. Prospective comparison of novel dark blood late gadolinium enhancement with conventional bright blood imaging for the detection of scar. J Cardiovasc Magn Reson 2017;19:91. [PMID: 29162123 DOI: 10.1186/s12968-017-0407-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
6 Domnin P, Arkhipova A, Petrov S, Sysolyatina E, Parfenov V, Karalkin P, Mukhachev A, Gusarov A, Moisenovich M, Khesuani Y, Ermolaeva S. An In Vitro Model of Nonattached Biofilm-Like Bacterial Aggregates Based on Magnetic Levitation. Appl Environ Microbiol 2020;86:e01074-20. [PMID: 32680859 DOI: 10.1128/AEM.01074-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Monti CB, Codari M, Cozzi A, Alì M, Saggiante L, Sardanelli F, Secchi F. Image quality of late gadolinium enhancement in cardiac magnetic resonance with different doses of contrast material in patients with chronic myocardial infarction. Eur Radiol Exp 2020;4:21. [PMID: 32242266 DOI: 10.1186/s41747-020-00149-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Scott LJ. Gadobutrol: A Review in Contrast-Enhanced MRI and MRA. Clin Drug Investig 2018;38:773-84. [PMID: 30006819 DOI: 10.1007/s40261-018-0674-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]